UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Thermal Elimination of Ethylene from Cyclobutyl Groups Characterized by X‐ray Crystallography in a Metal–Organic Framework Matrix

Chemistry : a European journal, 2020-08, Vol.26 (45), p.10321-10329

2020

Volltextzugriff (PDF)

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells

British journal of cancer, 1990-07, Vol.62 (1), p.37-41

1990

Volltextzugriff (PDF)

In vitro circumvention of anthracycline-resistance in ehrlich ascites tumour by anthracycline analogues

Biochemical pharmacology, 1990-06, Vol.39 (11), p.1721-1726

1990

Volltextzugriff (PDF)

Method for Determination of Intracellular Sodium in Perfused Cancer Cells by 23Na Nuclear Magnetic Resonance Spectroscopy

Analytical biochemistry, 1993-11, Vol.214 (2), p.506-510

1993

Volltextzugriff (PDF)

Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding

Biochemical pharmacology, 1998-11, Vol.56 (9), p.1209-1217

1998

Volltextzugriff (PDF)

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [ I]iodomycin and [ H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells

British journal of cancer, 1993-02, Vol.67 (2), p.226-231

1993

Volltextzugriff (PDF)

Multidrug resistance: Drug extrusion and its counteraction by chemosensitizers

European journal of haematology, 1989-06, Vol.42 (S48), p.59-67

1989

Volltextzugriff (PDF)

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators

British journal of cancer, 1989-12, Vol.60 (6), p.809-814

1989

Volltextzugriff (PDF)

Anthracycline Resistance

Acta oncologica, 1989, Vol.28 (6), p.877-881

1989

Volltextzugriff (PDF)

Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration

Biochemical pharmacology, 1998, Vol.55 (1), p.27-32

1998

Volltextzugriff (PDF)

Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells

Cancer chemotherapy and pharmacology, 2002-06, Vol.49 (6), p.453-460

2002

Volltextzugriff (PDF)

Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)

Biochemical pharmacology, 1993-08, Vol.46 (3), p.389-393

1993

Volltextzugriff (PDF)

Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide

Biochemical pharmacology, 2000-08, Vol.60 (3), p.353-361

2000

Volltextzugriff (PDF)

Characterisation of Non-P-Glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone

Biochemical pharmacology, 2000-08, Vol.60 (3), p.363-370

2000

Volltextzugriff (PDF)

Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance

Biochemical pharmacology, 1993-05, Vol.45 (10), p.2025-2035

1993

Volltextzugriff (PDF)

Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells

Cancer research (Chicago, Ill.), 1993-03, Vol.53 (6), p.1373-1379

1993

Volltextzugriff (PDF)

Refractoriness to α-interferon (Intron A) in previously chemotherapy-treated patients with chronic myelocytic leukaemia

European journal of haematology, 1988-04, Vol.40 (4), p.305-308

1988

Volltextzugriff (PDF)

Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells

Cancer research (Chicago, Ill.), 1991-08, Vol.51 (16), p.4213-4218

1991

Volltextzugriff (PDF)

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5093-5099

1991

Volltextzugriff (PDF)

Characterization of multidrug resistant Ehrlich ascites tumor cells (EHR2) selected for resistance to mitoxantrone (MITOX)

European journal of cancer (1990), 1997-09, Vol.33, p.S178-S178

1997

Volltextzugriff (PDF)

Relationship of VP-16 to the classical multidrug resistance phenotype

Cancer research (Chicago, Ill.), 1992-05, Vol.52 (10), p.2874-2879

1992

Volltextzugriff (PDF)

The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor

Cancer communications (New York), 1990, Vol.2 (9), p.297

1990

Volltextzugriff (PDF)

Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo

Cancer research (Chicago, Ill.), 1992-10, Vol.52 (20), p.5701-5706

1992

Volltextzugriff (PDF)

Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor

Cancer chemotherapy and pharmacology, 1992, Vol.30 (3), p.235-237

1992

Volltextzugriff (PDF)

Mechanism of resistance to anthracyclines and vinca alkaloids

Progress in clinical and biological research, 1983, Vol.132C, p.231

1983

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(55)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(27)
Biological And Medical Sciences
(27)
Medical Sciences
(23)
Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Pharmacology. Drug Treatments
(20)
Antineoplastic Agents
(19)
Drug Resistance
(16)
General Aspects
(16)
Humans
(14)
Carcinoma, Ehrlich Tumor - Metabolism
(13)
Mice
(12)
Tumor Cells, Cultured
(12)
Daunorubicin - Pharmacology
(11)
Carcinoma, Ehrlich Tumor - Drug Therapy
(10)
Oncology
(10)
Pharmacology & Pharmacy
(9)
Female
(7)
Daunorubicin - Metabolism
(6)
Male
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thermal Elimination of Ethylene from Cyclobutyl Groups Characterized by X‐ray Crystallography in a Metal–Organic Framework Matrix

Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells

In vitro circumvention of anthracycline-resistance in ehrlich ascites tumour by anthracycline analogues

Method for Determination of Intracellular Sodium in Perfused Cancer Cells by 23Na Nuclear Magnetic Resonance Spectroscopy

Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding

Effect of anthracycline analogs on photolabelling of p-glycoprotein by [ I]iodomycin and [ H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells

Multidrug resistance: Drug extrusion and its counteraction by chemosensitizers

Inhibition of vincristine binding to plasma membrane vesicles from daunorubicin-resistant Ehrlich ascites cells by multidrug resistance modulators

Anthracycline Resistance

Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration

Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells

Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)

Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide

Characterisation of Non-P-Glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone

Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance

Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells

Refractoriness to α-interferon (Intron A) in previously chemotherapy-treated patients with chronic myelocytic leukaemia

Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Characterization of multidrug resistant Ehrlich ascites tumor cells (EHR2) selected for resistance to mitoxantrone (MITOX)

Relationship of VP-16 to the classical multidrug resistance phenotype

The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor

Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo

Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor

Mechanism of resistance to anthracyclines and vinca alkaloids

Aktive Filter

Suchergebnisse filtern